Foghorn Therapeutics Inc.
@foghorntx.com
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system.
Foghorn Therapeutics Inc.'s Company Logos
Foghorn Therapeutics Inc.'s Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#61C7CE
Downy
97, 199, 206
184, 53, 59
53, 3, 0, 19
#7A3FF1
Electric Violet
122, 63, 241
260, 86, 60
49, 74, 0, 5
#180D43
Violet
24, 13, 67
252, 68, 16
64, 81, 0, 74
About Foghorn Therapeutics Inc.
Foghorn Therapeutics is a leading brand in the field of precision therapeutics. Their groundbreaking products and services aim to tackle diseases by remodeling the shape of DNA. With a focus on the chromatin regulatory system, which plays a crucial role in gene expression, Foghorn's precision therapeutic candidates have the potential to revolutionize the treatment of cancer and other serious diseases.
By targeting disease dependencies within this system, they can correct abnormal gene expression and restore balance to the body. Backed by a management team with extensive experience in discovering and commercializing new therapies, Foghorn is at the forefront of innovative medicine. They are also actively seeking passionate individuals to join their team and contribute to their mission of transforming the lives of people with a wide spectrum of diseases.
For more information about Foghorn Therapeutics, their pipeline, and latest developments, visit their website
Company type
Privately Held
Year founded
2016
Company size
51-200 employees
Related Brands
Tags
Chromatin regulatory system
Abnormal gene expression
Precision oncology therapeutics
Allosteric small-molecule inhibitors
BAF complex
